Pilot Study Investigating the Metabolic Activity and Transcriptional Profiling in Vivo in Tumor Biopsies in Melanoma Patients During Treatment With Pazopanib Alone and in Combination With Paclitaxel
PHASE2CompletedINTERVENTIONAL
Enrollment
19
Participants
Timeline
Start Date
August 31, 2012
Primary Completion Date
October 31, 2014
Study Completion Date
May 31, 2015
Conditions
Melanoma
Interventions
DRUG
Pazopanib/Paclitaxel
Trial Locations (1)
Unknown
University Hospital Zurich, Division of Dermatology, Zurich
All Listed Sponsors
lead
University of Zurich
OTHER
NCT01666418 - Pilot Study Investigating the Metabolic Activity and Transcriptional Profiling in Vivo in Tumor Biopsies in Melanoma Patients During Treatment With Pazopanib Alone and in Combination With Paclitaxel | Biotech Hunter | Biotech Hunter